<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14</volume><submitter>Hansel M</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>Patients' olfactory function after autoimmune encephalitis (AE) involving limbic structures may be impaired. This study aimed to characterize olfactory function in patients after autoimmune encephalitides.&lt;h4>Methods&lt;/h4>A case-control study was performed including 11 AE patients with antibodies against NMDAR (&lt;i>n&lt;/i> = 4), GAD (&lt;i>n&lt;/i> = 3), VGKC (&lt;i>n&lt;/i> = 3) and antibody-negative AE (&lt;i>n&lt;/i> = 1) and a control group of 12 patients with pneumococcal meningo-encephalitis (PC). In subgroup analyses, AE patients with and without NMDAR-antibodies were compared. Olfactory function was assessed using the Sniffin Sticks test and the resulting TDI-score (threshold, discrimination, identification). Involvement of limbic structures was evaluated on imaging data (MRI). Statist</pubmed_abstract><journal>Frontiers in neurology</journal><pagination>1225975</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10486887</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Olfactory dysfunction after autoimmune encephalitis depending on the antibody type and limbic MRI pathologies.</pubmed_title><pmcid>PMC10486887</pmcid><pubmed_authors>Schneider H</pubmed_authors><pubmed_authors>Reichmann H</pubmed_authors><pubmed_authors>Schmitz-Peiffer H</pubmed_authors><pubmed_authors>Hansel M</pubmed_authors><pubmed_authors>Hahner A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Olfactory dysfunction after autoimmune encephalitis depending on the antibody type and limbic MRI pathologies.</name><description>&lt;h4>Objective&lt;/h4>Patients' olfactory function after autoimmune encephalitis (AE) involving limbic structures may be impaired. This study aimed to characterize olfactory function in patients after autoimmune encephalitides.&lt;h4>Methods&lt;/h4>A case-control study was performed including 11 AE patients with antibodies against NMDAR (&lt;i>n&lt;/i> = 4), GAD (&lt;i>n&lt;/i> = 3), VGKC (&lt;i>n&lt;/i> = 3) and antibody-negative AE (&lt;i>n&lt;/i> = 1) and a control group of 12 patients with pneumococcal meningo-encephalitis (PC). In subgroup analyses, AE patients with and without NMDAR-antibodies were compared. Olfactory function was assessed using the Sniffin Sticks test and the resulting TDI-score (threshold, discrimination, identification). Involvement of limbic structures was evaluated on imaging data (MRI). Statist</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-04-04T19:37:29.738Z</modification><creation>2025-04-04T19:37:29.738Z</creation></dates><accession>S-EPMC10486887</accession><cross_references><pubmed>37693764</pubmed><doi>10.3389/fneur.2023.1225975</doi></cross_references></HashMap>